PEOPLE - CytoCore makes appointment:
This article was originally published in Clinica
Executive Summary
Augusto Ocana has been appointed CEO for US cancer screening systems company CytoCore (Chicago, Illinois), succeeding Dr David Weissberg. On the eve of the international launch of its new product, the e2Collector (Pap smear device), the company will leverage Dr Ocana's expertise in market distribution, strategic partnering, financing and business development. Previous positions held by Dr Ocana include senior vice-president and managing director at CH-Werfen (Barcelona), a healthcare group that manufactures and distributes diagnostics, medical devices and scientific instruments.